rxstat › Shortages › Sitagliptin

Sitagliptin shortage status

Widespread shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Sitagliptin is in a widespread shortage in Canada. 12 of 24 reported products are affected. The latest manufacturer estimate for full recovery is Jan 7, 2027.
Products affected
12 of 24
In shortage since
Mar 20, 2024
Est. full return
Jan 7, 2027
Reports on file
47
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
PRO-SITAGLIPTIN MALATE
100MG · TABLET · PRO DOC LIMITEE
DIN 02534312 · since Jul 7, 2026, no end estimate · Other (Please describe in comments)
Active shortage
PMS-SITAGLIPTIN
50MG · TABLET · PHARMASCIENCE INC
DIN 02503859 · since Jul 3, 2025, est. end Jan 7, 2027 · Disruption of the manufacture of the drug.
Active shortage
JAMP SITAGLIPTIN
100MG · TABLET · JAMP PHARMA CORPORATION
DIN 02534150 · since Mar 12, 2026, est. end Aug 7, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-SITAGLIPTIN MALATE
100MG · TABLET · APOTEX INC
DIN 02508672 · since Aug 12, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-SITAGLIPTIN MALATE
100MG · TABLET · APOTEX INC
DIN 02508672 · since Oct 14, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-SITAGLIPTIN MALATE
50MG · TABLET · APOTEX INC
DIN 02508664 · since Nov 4, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-SITAGLIPTIN MALATE
50MG · TABLET · APOTEX INC
DIN 02508664 · since Nov 18, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-SITAGLIPTIN MALATE
25MG · TABLET · APOTEX INC
DIN 02508656 · since Oct 14, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-SITAGLIPTIN MALATE
25MG · TABLET · APOTEX INC
DIN 02508656 · since Oct 14, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-SITAGLIPTIN MALATE
100MG · TABLET · APOTEX INC
DIN 02508672 · since Oct 14, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TEVA-SITAGLIPTIN MALATE
50MG · TABLET · TEVA CANADA LIMITED
DIN 02522713 · since Mar 5, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TEVA-SITAGLIPTIN MALATE
25MG · TABLET · TEVA CANADA LIMITED
DIN 02522705 · since Mar 5, 2025, no end estimate · Disruption of the manufacture of the drug.

Showing 12 of 47 reports. All reports are on file with Health Canada.

What's happening

Sitagliptin is currently affected by 12 active shortage reports filed with Health Canada by PRO DOC LIMITEE, PHARMASCIENCE INC, JAMP PHARMA CORPORATION, APOTEX INC and 2 others.

The reported causes are: other (please describe in comments); disruption of the manufacture of the drug; requirements related to complying with good manufacturing practices. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Sitagliptin is classified under “BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS” (ATC A10BH).

Recent changes

Common questions

When will Sitagliptin be back in stock in Canada?

The latest manufacturer estimate is Jan 7, 2027. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Sitagliptin in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (blood glucose lowering drugs, excl. insulins)

Widespread shortageCanagliflozin2 of 4 reported products affected · est. return Dec 4, 2026Widespread shortageTirzepatide6 of 6 reported products affectedPartial shortageDapagliflozin4 of 11 reported products affected · est. return Jul 24, 2026Partial shortageDapagliflozin Metformin2 of 6 reported products affected · est. return Jul 24, 2026Partial shortageGliclazide2 of 20 reported products affectedPartial shortageMetformin3 of 33 reported products affected · est. return May 15, 2026

All blood glucose lowering drugs, excl. insulins shortage statuses →

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.